Unlike GLP-1 agonists, DPP-4 inhibitors do not affect satiety, gastric emptying, or induce weight loss
However, due to the progressive nature of diabetes, a second-line medication is commonly required at some point in the course of the disease to maintain glucose homeostasis
We are now offering these weight loss shots at Sant Medical Aesthetics to find the right solution for finally losing weight and keeping it off
Impact of Selected Glucagon-like Peptide-1 Receptor Agonists on Serum Lipids, Adipose Tissue, and Muscle Metabolism-A Narrative Review
Discontinuing glucagonlike peptide-1 receptor agonists and body habitus: A systematic review and meta-analysis
The specific criteria for inclusion and exclusion of relevant studies in terms of PI(E)COS (Population, Intervention/Exposure, Comparison, Outcomes, and Study design) are provided in Table 1